Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts

Ginkgo Bioworks (DNA) closed at $7.06, up 1% while the broader market declined. The stock has gained 7.04% over the past month, outperforming the Medical sector. However, analysts expect significant revenue decline of 47.22% in the upcoming quarter and 51.69% for the full year, with continued losses. The company holds a Zacks Rank of #3 (Hold), and its industry ranks in the bottom 33% of sectors.